首页> 外国专利> Salts of duloxetine, Enhanced Synthesis of the compound and Pharmaceutical formulation

Salts of duloxetine, Enhanced Synthesis of the compound and Pharmaceutical formulation

机译:度洛西汀盐,化合物的增强合成和药物制剂

摘要

Salts and improved process to prepare Duloxetine Duloxetine Hydrochloride. More particularly, This relates to the preparation of Duloxetine Hydrochloride by a process that provides a maximum yield of the desired product with a minimum amount of unwanted side products. These compounds are useful in the treatment of Depressive Disorders.Claim 1 is characterized in that: a Compound, 4 - (3 - metilamin - 1 - thiophen-2-yl - propyl) - naftalen - 1 - ol (u00f4compuesto2u00f6) of formula (1) and salts thereof, where the hydrochloride Salt of the compound 2 is characterized by 1H NMR (400 MHz, DMSO) with characteristic Peaks 10.17 (1H, S) - 8.8 9.1 (2H, s width, 8,16 (1H), (d), 8 (7.48 (1H, 1h, (d), (T), 7.42 7.33 (1H, 1h, T), (d), 7.28 (1H, (d), 704 (6.92 (1H, 1h, (d), T, 6.89 (1H), D (1H), 5.09, T, (char), 2.85 m (2H, 5H, and 2.56 m approximately).
机译:用盐和改进的方法制备度洛西汀盐酸盐。更具体地,本发明涉及通过提供最大产率的所需产物和最小量的不需要的副产物的方法制备盐酸度洛西汀。这些化合物可用于治疗抑郁症。权利要求1的特征在于:一种化合物4-(3--甲拉明-1-噻吩-2-基-丙基)-萘芬-1-ol( u00f4compuesto2 u00f6)式(1)的化合物及其盐,其中化合物2的盐酸盐通过1H NMR(400 MHz,DMSO)表征,特征峰为10.17(1H,S)-8.8 9.1(2H,s宽度为8,16( 1H),(d),8(7.48(1H,1h,(d),(T),7.42 7.33(1H,1h,T),(d),7.28(1H,(d),704(6.92(1H) ,1h,(d),T,6.89(1H),D(1H),5.09,T,(char),2.85 m(大约2H,5H和2.56 m)。

著录项

  • 公开/公告号AR058320A1

    专利类型

  • 公开/公告日2008-01-30

    原文格式PDF

  • 申请/专利权人 MEDICHEM S.A.;

    申请/专利号AR2006P105467

  • 发明设计人 WINTER STEPHEN;

    申请日2006-12-12

  • 分类号C07D333/10;A61K31/391;A61P25/24;

  • 国家 AR

  • 入库时间 2022-08-21 20:08:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号